KD Logo

Recent Insider Activity Could Benefit Acadia Pharmaceuticals Inc (ACAD)

ZOM Stock

Acadia Pharmaceuticals Inc’s recent filing unveils that its CEO DAVIS STEPHEN unloaded Company’s shares for reported $0.19 million on May 02 ’24. In the deal valued at $16.94 per share,11,427 shares were sold. As a result of this transaction, DAVIS STEPHEN now holds 155,231 shares worth roughly $2.37 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Schneyer Mark C. sold 3,503 shares, generating $59,341 in total proceeds. Upon selling the shares at $16.94, the EVP, CHIEF FINANCIAL OFFICER now owns 32,053 shares.

Before that, Teehan Brendan sold 3,477 shares. Acadia Pharmaceuticals Inc shares valued at $58,900 were divested by the EVP, COO, HEAD OF COMMERCIAL at a price of $16.94 per share. As a result of the transaction, Teehan Brendan now holds 42,133 shares, worth roughly $0.64 million.

Needham reiterated its Acadia Pharmaceuticals Inc [ACAD] rating to a Buy in a research note published on March 12, 2024; the price target was $32. A number of analysts have revised their coverage, including Mizuho’s analysts, who decreased its forecast for the stock in mid March from “a Buy” to “a Neutral”. Robert W. Baird began covering ACAD with “an Outperform” recommendation on January 30, 2024. Needham revised its rating on January 24, 2024. It rated ACAD as “a Buy” which previously was an “a Hold”.

Price Performance Review of ACAD

On Friday, Acadia Pharmaceuticals Inc [NASDAQ:ACAD] saw its stock jump 0.26% to $15.25. Over the last five days, the stock has lost -10.56%. Acadia Pharmaceuticals Inc shares have fallen nearly -51.29% since the year began. Nevertheless, the stocks have fallen -29.56% over the past one year. While a 52-week high of $33.99 was reached on 01/02/24, a 52-week low of $15.17 was recorded on 05/10/24. SMA at 50 days reached $18.43, while 200 days put it at $23.81. A total of 2.31 million shares were traded, compared to the trading of 5.28 million shares in the previous session.

Levels Of Support And Resistance For ACAD Stock

The 24-hour chart illustrates a support level at 15.06, which if violated will result in even more drops to 14.88. On the upside, there is a resistance level at 15.48. A further resistance level may holdings at 15.72. The Relative Strength Index (RSI) on the 14-day chart is 27.51, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.79, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 94.34%. Stochastics %K at 25.15% indicates the stock is a holding.

Most Popular